Yield10 Bioscience Inc (YTEN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: MISCELLANEOUS PLASTICS PRODUCTS

19 PRESIDENTIAL WAY WOBURN, MA 01801

Yield10 Bioscience, Inc. operates as an agricultural bioscience company. The Company focuses on the development of disruptive technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. Yield10 Bioscience offers its services in the United States.

Data as of 2020-09-12
Market Cap22.369 Million Shares Outstanding3.214 Million Avg 30-day Volume2.56 Million
P/E Ratio Dividend Yield EPS-24.14
Price/Sales25.667 Price cash flow ratio Price free cash flow ratio-2.5
Book Value2.64 Price to Tangible Book2.64 Alpha-0.07
Short Interest Ratio % Short Interest to Float R-squared0.139536
BETA2.56331 52-week High/Low31.048 / 3.5 Stddev0.293202
View SEC Filings from YTEN instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 11 11 0.0% 1 (0.07%) 1 (0.06%) 0.0%
13F shares: 120.288 Thousand 113.483 Thousand 6.0% 18.952 Thousand 18.952 Thousand 0.0%
% Ownership 6.1051 5.9008 3.46% 0.9619 0.9854 -2.38%
New Positions: 1 2 -50.0%
Increased Positions 3
Closed Positions 1 7 -85.71% 3
Reduced Positions 2 4 -50.0% 1
Total Calls 0 0
Total Puts 0 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding YTEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding YTEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

365.2 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SCHULER JACK W

  • 10% Owner
793,635 2020-08-26 3

BRUM LYNNE H VP PLANNING & COMMS

  • Officer
5,938 2020-08-11 3

PEOPLES OLIVER P PRES & CEO

  • Officer
  • Director
9,394 2020-08-11 4

HAASER CHARLES B VP FIN & CHIEF ACCTING OFFICER

  • Officer
5,941 2020-08-11 3

SNELL KRISTI VP RESEARCH & CSO

  • Officer
6,407 2020-08-11 3

SINSKEY ANTHONY J

  • Director
0 2020-06-30 4

VAN NOSTRAND ROBERT L

  • Director
0 2020-06-30 4

HAMILTON RICHARD WILLIAM

  • Director
0 2020-05-28 1

BROWN SHERRI M.

  • Director
0 2020-05-28 3

SHAULSON JOSEPH H

  • Director
0 2020-05-19 4

KELLOGG PETER N

  • Director
0 2019-05-22 0

SCULLY WILLIAM P

  • 10% Owner
2,933,333 2016-09-12 0

VAN WALSEM JOHAN CHIEF OPERATING OFFICER

  • Officer
276,938 2016-04-01 0

CECIL SARAH P GENERAL COUNSEL

  • Officer
78,661 2016-04-01 0

STROBECK MATTHEW

  • Director
2,284,934 2016-01-27 0

MASTIN CELESTE BEEKS

  • Director
12,500 2015-09-10 0

SCHULER FAMILY FOUNDATION

  • 10% Owner
9,784,143 2015-06-19 0

BIRCHVIEW CAPITAL GP, LLC

BIRCHVIEW CAPITAL, LP

BIRCHVIEW FUND LLC

BIRCHVIEW PARTNERS, LLC

  • Director
710,366 2015-06-19 0

SCHULER RENATE R

  • 10% Owner
50,600 2014-08-22 0

LARGE STEPHEN J

  • Director
0 2013-06-06 0

WELLS BARBARA H

  • Director
0 2013-06-06 0

KOUBA JAY

  • Director
0 2013-06-06 0

ENO RICHARD P PRES. AND CEO

  • Officer
  • Director
0 2013-05-30 0

HILL JOSEPH D CFO

  • Officer
0 2013-05-30 0

ENGLE ROBERT E VP BIOPOLYMERS

  • Officer
0 2013-05-30 0

SENECHAL MAX VP, BIO-BASED CHEMICALS

  • Officer
0 2013-05-30 0

MULLER EDWARD M

  • Director
735,091 2012-06-08 0

GILES EDWARD M

  • Director
0 2011-05-26 0

KATRAGADDA ANINDA DIR. FIN. AND CORP. CONTROLLER

  • Officer
0 2008-05-30 0

FINDLEN ROBERT VP MARKETING

  • Officer
0 2008-05-30 0

LASERSOHN JACK W

  • Director
No longer subject to file 2008-05-29 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SCHULER JACK W - > 10% Owner see footnote

2020-08-31 07:00:20 -0400 2020-08-26 P 365,241 $4.25 a 793,635 indirect

BRUM LYNNE H - Officer VP PLANNING & COMMS

2020-08-13 18:00:30 -0400 2020-08-11 F 587 $6.55 d 3,599 direct

SNELL KRISTI - Officer VP RESEARCH & CSO

2020-08-13 18:06:02 -0400 2020-08-11 F 587 $6.55 d 3,525 direct

PEOPLES OLIVER P - Director - Officer PRES & CEO

2020-08-13 18:13:04 -0400 2020-08-11 F 733 $6.55 d 5,953 direct

HAASER CHARLES B - Officer VP FIN & CHIEF ACCTING OFFICER

2020-08-13 18:01:57 -0400 2020-08-11 F 587 $6.55 d 3,468 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments